pharma · Acute Myeloid Leukemia · Acute Leukemia · ATNM
Actinium Pharmaceuticals
Actinium Pharmaceuticals trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
New York, USA HQ
2000 Founded
58 Employees
Public company Type
ATNM · NYSE Ticker
Company details
- Status
- Public
- HQ
- New York, USA
- Founded
- 2000
- Employees
- 58
- Programs
- 8
- Drugs
- 4
- Patents
- 20
Actinium Pharmaceuticals clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to Actinium Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Actinium Pharmaceuticals trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Actinium Pharmaceuticals.
-
Cytarabine (Phase 1 only) — Phase 2
Clinical update -
ACTINIUM-225-LABELED HUMANIZED ANTI-CD33 MONOCLONAL ANTIBODY HuM195 — Phase 1
Clinical update -
131I-apamistamab — Phase 3
Clinical update -
Iomab-B — Phase 3
Clinical update -
Iomab-B — Phase 2
Clinical update -
Lintuzumab-Ac225 — Phase 2
Clinical update -
131I-apamistmab — Phase 1
Clinical update -
Lintuzumab AC 225 — Phase 1
Clinical update